NCT04088474View on ClinicalTrials.gov

Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 5, 2016

Primary Completion Date

July 6, 2016

Study Completion Date

December 18, 2016

Conditions
Gastrointestinal Microbiome
Interventions
DIETARY_SUPPLEMENT

Vigiis 101-LAB

examined the effects of the Vigiis 101-LAB capsules (5 billion CFU/day)

DIETARY_SUPPLEMENT

Placebo

Maltodextrin was used as a placebo

Trial Locations (1)

104

Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei

All Listed Sponsors
lead

SunWay Biotech Co., LTD.

INDUSTRY

NCT04088474 - Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora | Biotech Hunter | Biotech Hunter